UG Healthcare Corporation Limited (SGX:8K7)
Singapore · Delayed Price · Currency is SGD 0.0770
+0.0010 (1.32%)
At close: Sep 9, 2026
UG Healthcare Corporation Ratios and Metrics
Market cap in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 48 | 48 | 68 | 75 | 90 | 137 | |
Market Cap Growth | -26.67% | -29.36% | -9.17% | -16.67% | -34.54% | -61.27% |
Enterprise Value | 59 | 65 | 87 | 58 | 38 | 68 |
Last Close Price | 0.08 | 0.08 | 0.11 | 0.12 | 0.14 | 0.21 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 22.89 | 22.89 | - | - | - | 3.73 |
Forward PE | - | 5.33 | 5.33 | 5.33 | 5.33 | 4.54 |
PS Ratio | 0.32 | 0.32 | 0.47 | 0.65 | 0.89 | 0.59 |
PB Ratio | 0.28 | 0.28 | 0.42 | 0.45 | 0.50 | 0.58 |
P/TBV Ratio | 0.32 | 0.32 | 0.49 | 0.52 | 0.50 | 0.60 |
P/FCF Ratio | 3.35 | 3.35 | - | - | - | 4.13 |
P/OCF Ratio | 2.83 | 2.83 | - | - | - | 2.54 |
PEG Ratio | - | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.39 | 0.43 | 0.61 | 0.50 | 0.37 | 0.29 |
EV/EBITDA Ratio | 5.17 | 5.70 | 37.95 | - | - | 1.25 |
EV/EBIT Ratio | 10.59 | 11.71 | - | - | - | 1.32 |
EV/FCF Ratio | 4.12 | 4.54 | - | - | - | 2.03 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.24 | 0.24 | 0.30 | 0.26 | 0.17 | 0.08 |
Debt / EBITDA Ratio | 3.55 | 3.55 | 16.26 | - | - | 0.33 |
Debt / FCF Ratio | 2.83 | 2.83 | - | - | - | 0.54 |
Net Debt / Equity Ratio | 0.08 | 0.08 | 0.15 | 0.10 | -0.17 | -0.35 |
Net Debt / EBITDA Ratio | 1.15 | 1.15 | 10.45 | -4.56 | 1.37 | -1.52 |
Net Debt / FCF Ratio | 0.91 | 0.91 | -3.98 | -1.42 | 0.69 | -2.48 |
Asset Turnover | 0.63 | 0.63 | 0.62 | 0.50 | 0.39 | 0.84 |
Inventory Turnover | 1.75 | 1.75 | 1.74 | 1.54 | 1.71 | 2.21 |
Quick Ratio | 1.60 | 1.60 | 1.35 | 1.82 | 3.07 | 3.99 |
Current Ratio | 2.82 | 2.82 | 2.70 | 3.58 | 4.88 | 5.74 |
Return on Equity (ROE) | 1.61% | 1.61% | -2.90% | -3.85% | -12.96% | 18.52% |
Return on Assets (ROA) | 1.46% | 1.46% | -0.22% | -1.80% | -6.06% | 11.50% |
Return on Invested Capital (ROIC) | 2.01% | 2.00% | -0.45% | -3.99% | -16.56% | 28.23% |
Return on Capital Employed (ROCE) | 2.90% | 2.90% | -0.40% | -3.40% | -12.70% | 20.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 8, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | 4.37% | 4.37% | -6.02% | -5.29% | -23.08% | 26.81% |
FCF Yield | 29.86% | 29.86% | -8.90% | -14.82% | -49.76% | 24.20% |
Dividend Yield | - | - | - | - | - | 1.50% |
Payout Ratio | - | - | - | - | - | 1.62% |
Buyback Yield / Dilution | - | - | - | - | -0.58% | -1.43% |
Total Shareholder Return | - | - | - | - | -0.58% | 0.07% |